Literature DB >> 31601573

Bayesian Estimation of CBF Measured by DSC-MRI in Patients with Moyamoya Disease: Comparison with 15O-Gas PET and Singular Value Decomposition.

S Hara1,2, Y Tanaka3, S Hayashi3,4, M Inaji3,4, T Maehara3, M Hori2, S Aoki2, K Ishii4, T Nariai3,4.   

Abstract

BACKGROUND AND
PURPOSE: CBF analysis of DSC perfusion using the singular value decomposition algorithm is not accurate in patients with Moyamoya disease. This study compared the Bayesian estimation of CBF against the criterion standard PET and singular value decomposition methods in patients with Moyamoya disease.
MATERIALS AND METHODS: Nineteen patients with Moyamoya disease (10 women; 22-52 years of age) were evaluated with both DSC and 15O-gas PET within 60 days. DSC-CBF maps were created using Bayesian analysis and 3 singular value decomposition analyses (standard singular value decomposition, a block-circulant deconvolution method with a fixed noise cutoff, and a block-circulant deconvolution method that adopts an occillating noise cutoff for each voxel according to the strength of noise). Qualitative and quantitative analyses of the Bayesian-CBF and singular value decomposition-CBF methods were performed against 15O-gas PET and compared with each other.
RESULTS: In qualitative assessments of DSC-CBF maps, Bayesian-CBF maps showed better visualization of decreased CBF on PET (sensitivity = 62.5%, specificity = 100%, positive predictive value = 100%, negative predictive value = 78.6%) than a block-circulant deconvolution method with a fixed noise cutoff and a block-circulant deconvolution method that adopts an oscillating noise cutoff for each voxel according to the strength of noise (P < .03 for all except for specificity). Quantitative analysis of CBF showed that the correlation between Bayesian-CBF and PET-CBF values (ρ = 0.46, P < .001) was similar among the 3 singular value decomposition methods, and Bayesian analysis overestimated true CBF (mean difference, 47.28 mL/min/100 g). However, the correlation between CBF values normalized to the cerebellum was better in Bayesian analysis (ρ = 0.56, P < .001) than in the 3 singular value decomposition methods (P < .02).
CONCLUSIONS: Compared with previously reported singular value decomposition algorithms, Bayesian analysis of DSC perfusion enabled better qualitative and quantitative assessments of CBF in patients with Moyamoya disease.
© 2019 by American Journal of Neuroradiology.

Entities:  

Mesh:

Year:  2019        PMID: 31601573      PMCID: PMC6975120          DOI: 10.3174/ajnr.A6248

Source DB:  PubMed          Journal:  AJNR Am J Neuroradiol        ISSN: 0195-6108            Impact factor:   3.825


  33 in total

1.  Correlation between Clinical Presentations and Hemodynamic Parameters Measured by Dynamic Susceptibility Contrast Magnetic Resonance Imaging in Adult Patients with Moyamoya Disease.

Authors:  Sakyo Hirai; Motoki Inaji; Yoji Tanaka; Shoko Hara; Tadashi Nariai; Taketoshi Maehara
Journal:  J Stroke Cerebrovasc Dis       Date:  2017-08-01       Impact factor: 2.136

2.  Bayesian hemodynamic parameter estimation by bolus tracking perfusion weighted imaging.

Authors:  Timothé Boutelier; Koshuke Kudo; Fabrice Pautot; Makoto Sasaki
Journal:  IEEE Trans Med Imaging       Date:  2012-03-06       Impact factor: 10.048

3.  Quantitative evaluation of cerebral hemodynamics in patients with moyamoya disease by dynamic susceptibility contrast magnetic resonance imaging--comparison with positron emission tomography.

Authors:  Yoji Tanaka; Tadashi Nariai; Tsukasa Nagaoka; Hideaki Akimoto; Kiichi Ishiwata; Kenji Ishii; Yoshiharu Matsushima; Kikuo Ohno
Journal:  J Cereb Blood Flow Metab       Date:  2006-02       Impact factor: 6.200

4.  Automatic selection of arterial input function using cluster analysis.

Authors:  Kim Mouridsen; Søren Christensen; Louise Gyldensted; Leif Ostergaard
Journal:  Magn Reson Med       Date:  2006-03       Impact factor: 4.668

5.  High resolution measurement of cerebral blood flow using intravascular tracer bolus passages. Part I: Mathematical approach and statistical analysis.

Authors:  L Ostergaard; R M Weisskoff; D A Chesler; C Gyldensted; B R Rosen
Journal:  Magn Reson Med       Date:  1996-11       Impact factor: 4.668

6.  Cerebrovascular occlusive disease: quantitative cerebral blood flow using dynamic susceptibility contrast mr imaging correlates with quantitative H2[15O] PET.

Authors:  Parmede Vakil; John J Lee; Jessy J Mouannes-Srour; Colin P Derdeyn; Timothy J Carroll
Journal:  Radiology       Date:  2013-01-07       Impact factor: 11.105

7.  Reliable estimation of microvascular flow patterns in patients with disrupted blood-brain barrier using dynamic susceptibility contrast MRI.

Authors:  Mikkel Bo Hansen; Anna Tietze; Jayashree Kalpathy-Cramer; Elizabeth R Gerstner; Tracy T Batchelor; Leif Østergaard; Kim Mouridsen
Journal:  J Magn Reson Imaging       Date:  2016-11-30       Impact factor: 4.813

8.  Noninvasive Evaluation of CBF and Perfusion Delay of Moyamoya Disease Using Arterial Spin-Labeling MRI with Multiple Postlabeling Delays: Comparison with 15O-Gas PET and DSC-MRI.

Authors:  S Hara; Y Tanaka; Y Ueda; S Hayashi; M Inaji; K Ishiwata; K Ishii; T Maehara; T Nariai
Journal:  AJNR Am J Neuroradiol       Date:  2017-02-16       Impact factor: 3.825

9.  Chronologic Evaluation of Cerebral Hemodynamics by Dynamic Susceptibility Contrast Magnetic Resonance Imaging After Indirect Bypass Surgery for Moyamoya Disease.

Authors:  Yosuke Ishii; Yoji Tanaka; Toshiya Momose; Motoshige Yamashina; Akihito Sato; Shinichi Wakabayashi; Taketoshi Maehara; Tadashi Nariai
Journal:  World Neurosurg       Date:  2017-09-08       Impact factor: 2.104

10.  How reliable is perfusion MR in acute stroke? Validation and determination of the penumbra threshold against quantitative PET.

Authors:  Masashi Takasawa; P Simon Jones; Joseph V Guadagno; Soren Christensen; Tim D Fryer; Sally Harding; Jonathan H Gillard; Guy B Williams; Franklin I Aigbirhio; Elizabeth A Warburton; Leif Østergaard; Jean-Claude Baron
Journal:  Stroke       Date:  2008-02-07       Impact factor: 7.914

View more
  3 in total

1.  Spatial coefficient of variation of arterial spin labeling MRI for detecting hemodynamic disturbances measured with 15O-gas PET in patients with moyamoya disease.

Authors:  Shoko Hara; Yoji Tanaka; Motoki Inaji; Shihori Hayashi; Kenji Ishii; Tadashi Nariai; Taketoshi Maehara
Journal:  Neuroradiology       Date:  2021-09-09       Impact factor: 2.804

2.  Time to peak and full width at half maximum in MR perfusion: valuable indicators for monitoring moyamoya patients after revascularization.

Authors:  Adam Huang; Chung-Wei Lee; Hon-Man Liu
Journal:  Sci Rep       Date:  2021-01-12       Impact factor: 4.379

Review 3.  Progression in Moyamoya Disease: Clinical Features, Neuroimaging Evaluation, and Treatment.

Authors:  Xin Zhang; Weiping Xiao; Qing Zhang; Ding Xia; Peng Gao; Jiabin Su; Heng Yang; Xinjie Gao; Wei Ni; Yu Lei; Yuxiang Gu
Journal:  Curr Neuropharmacol       Date:  2022       Impact factor: 7.708

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.